Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Glycosylated PACAP/VIP analogues with enhanced CNS penetration for treatment of neurodegenerative diseases

Glycosylated PACAP/VIP analogues with enhanced CNS penetration for treatment of neurodegenerative diseases

US Patent 10117907 · Granted Nov 6, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Micelles and vesicles for the delivery of glycopeptides2025
Ang (1-7) derivative oligopeptides for the treatment of pain2025
Ang (1-7) derivative oligopeptides and methods for using and producing the same2024
Micelles and vesicles for the delivery of glycopeptides2022
Compositions and methods for treating motor disorders2022
Carbohydrate-based surfactants2021
Ang (1-7) derivative oligopeptides and methods for using and producing the same2021
Ang (1-7) derivative oligopeptides for the treatment of pain2021
Glycosylated peptides with pseudoproline residues and having enhanced half-lives2020
Ang (1-7) derivative oligopeptides and methods for using and producing the same2020
Ang-(1-7) derivative oligopeptides for the treatment of pain and other indicatio2019
Ang-(1-7) derivative oligopeptides and methods for using and producing the same2017